S37 Knowledge, Attitude, and the Practices in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP) Among Advanced Endoscopists

Tailor, Chintan S.; Chauhan, Shamshersingh; B, Kiran; Shah, Mit; Rawat, Vikramaditya L.; Walke, Swapnil; Jadhav, Rakesh R.; Vishwanathan, Deepti; Chaudhari, Vipul; Kolhe, Kailash; Ingle, Meghraj; Pandey, Vikas

doi:10.14309/01.ajg.0000772128.62640.f2

Am J Gastroenterol

2021

DOI: 10.14309/01.ajg.0000772128.62640.f2

|View full text |Cite

S37 Knowledge, Attitude, and the Practices in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP) Among Advanced Endoscopists

Chintan S. Tailor

Shamshersingh Chauhan

Kiran B

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Nonsteroidal Anti-inflammatory Drugs for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

Zuo,

Li,

Zhang

et al. 2024

Dig Dis Sci

View full text Add to dashboard Cite

Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) remains the most frequent and severe complication following ERCP, elevating both patient suffering and healthcare costs, and posing challenges to the advancement of ERCP techniques. Empirical evidence supports the prophylactic use of nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of PEP, especially in high-risk populations, as endorsed by both the American Society for Gastrointestinal Endoscopy (ASGE) and the European Society for Gastrointestinal Endoscopy (ESGE). However, the prophylactic efficacy of NSAIDs in average-risk individuals, alongside the ideal drug selection, dosing, and timing of NSAID administration, remains to be elucidated. Furthermore, the synergistic preventive potential of NSAIDs when integrated with other interventions, such as hydration, pancreatic stenting, somatostatin administration, sublingual nitrate application, and epinephrine, warrants further clarification. In this paper, we conduct an exhaustive review of the prophylactic effect and clinical administration of NSAIDs for PEP. We comprehensively synthesize findings from clinical trials investigating NSAIDs, both in monotherapy and combination regimens, for PEP prevention. Additionally, we scrutinize the current landscape of NSAID usage in clinical practice and evaluate their cost-effectiveness. Future research should concentrate on refining NSAID prophylaxis strategies for PEP in patients at different risk levels, while also enhancing adherence to clinical guidelines and alleviating the issue of NSAID cost inflation.

show abstract

Nonsteroidal Anti-inflammatory Drugs for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

Zuo,

Li,

Zhang

et al. 2024

Dig Dis Sci

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

S37 Knowledge, Attitude, and the Practices in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP) Among Advanced Endoscopists

Cited by 1 publication

References 0 publications

Nonsteroidal Anti-inflammatory Drugs for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

Nonsteroidal Anti-inflammatory Drugs for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

Contact Info

Product

Resources

About